Research Topics
| June M McKoySummaryAffiliation: Northwestern University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) ProjectJune M McKoy
The Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Drug Saf 36:335-47. 2013....
Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) projectJune M McKoy
Department of Medicine, Northwestern University Feinberg School of Medicine, and Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois 60611, USA
Drug Saf 32:147-58. 2009..We describe the incidence of hepatotoxicity with short- versus long-course nevirapine-containing regimens in these groups...- Epoetin-associated pure red cell aplasia: past, present, and future considerationsJune M McKoy
Division of Hematology Oncology and Geriatric Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
Transfusion 48:1754-62. 2008..In 1998, epoetin-associated pure red cell aplasia (PRCA) was first reported and causation was attributed to formulations without human serum albumin (HSA), subcutaneous administration, and uncoated rubber stoppers... - Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemiaCharles L Bennett
VA Chicago Healthcare System, Department of Medicine, Northwestern University Feinberg School of Medicine, and Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois 60611, USA
JAMA 299:914-24. 2008..Although systematic overviews of trials have identified venous thromboembolism (VTE) risks, none have identified mortality risks with ESAs... - Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR ProjectCharles L Bennett
VA Center for Management of Complex Chronic Care at Jesse Brown VA Medical Center, Division of Hematology Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA
J Am Coll Cardiol 50:1138-43. 2007..We sought to describe clinical and laboratory findings for a large cohort of patients with thienopyridine-associated thrombotic thrombocytopenic purpura (TTP)... 
Reassessments of ESAs for cancer treatment in the US and EuropeCharles L Bennett
VA Center for the Management of Complex Chronic Care, VA Chicago Healthcare System, Chicago, Illinois, USA
Oncology (Williston Park) 24:260-8. 2010..In contrast to Europe, where ESA use has increased over time, reassessments of ESA-associated safety concerns in the United States have resulted in marked decrements in ESA use among cancer patients...- Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) ProjectCharles L Bennett
MidWest Center for Health Services Research and Policy Studies, VA Chicago Healthcare System, Chicago, IL, USA
Blood 106:3343-7. 2005..Reinitiation of epoetin therapy among individuals could be considered if antierythropoietin antibodies are undetectable... - Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) projectCharles L Bennett
VA Midwest Center for Health Services and Policy Research, the Jesse Brown VA Medical Center, Chicago, IL, USA
Br J Haematol 135:642-50. 2006..While a causal relationship with haematological malignancies cannot be demonstrated, long-term follow-up among healthy individuals who receive haematopoietic growth factors is needed... - Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screeningVeena Shankaran
Veterans Affairs VA Chicago Healthcare System and VA Center for Management of Complex and Chronic Care, Chicago, IL, USA
J Clin Oncol 27:5370-5. 2009..The objective of this secondary analysis is to assess the cost effectiveness of this intervention... - Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) projectJune M McKoy
Division of Geriatric Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, 303 E Chicago, Chicago, IL 60611, USA
Leuk Res 31:599-604. 2007.... - Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?Elizabeth A Richey
Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, 303 E Chicago Ave, Chicago, IL 60611, USA
J Clin Oncol 27:4398-405. 2009.... - Adverse effects of drugs used to treat hematologic malignancies: surveillance efforts from the research on adverse drug events and reports projectCharles L Bennett
Veterans Affairs Center of Complex Chronic Care, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois, USA
Semin Thromb Hemost 33:365-72. 2007..This article reviews the features of the safety program maintained by the U.S. Food and Drug Administration and the RADAR program... - Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugsJune M McKoy
Jesse Brown Veterans Affairs Medical Center Lakeside Community-Based Outpatient Clinic, IL, USA
J Clin Oncol 23:8894-905. 2005..This is expected to greatly impact the practice of outpatient oncology nationwide... - Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietinJune M McKoy
Division of Geriatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA
Cancer Treat Res 140:235-51. 2008 - Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturersCharles L Bennett
Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Arch Intern Med 167:1041-9. 2007..We compare safety efforts for evaluating serious ADRs conducted by the FDA and pharmaceutical manufacturers vs the RADAR project... - Systematic review of piperacillin-induced neutropeniaMarc H Scheetz
Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL 60611, USA
Drug Saf 30:295-306. 2007..Report of neutropenia associated with piperacillin usage prior to 15 days of therapy is a novel finding that requires further evaluation. Current reporting methods poorly characterise patient groups at risk... - Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jawBeatrice J Edwards
Divisions of Hematology Oncology and Geriatric Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL USA
Lancet Oncol 9:1166-72. 2008..Better coordination of safety-related pharmacovigilance initiatives is now needed... - Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancerBeatrice J Edwards
Bone Health and Osteoporosis Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
Clin Cancer Res 17:560-8. 2011..Aromatase inhibitors (AIs) have been recently associated with hip fractures. We present a case series of breast cancer survivors and a systematic review of bone health care in breast cancer... - Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal functionPhilip Chang
Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Acad Radiol 19:1181-5. 2012..This study was done to evaluate the effectiveness of a pre-MR screening questionnaire about kidney disease and to assess POC eGFR detection of additional patients at risk for nephrogenic systemic fibrosis... - Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among VeteransMichael S Wolf
Institute for Healthcare Studies, Department of Medicine, Northwestern University, Illinois, USA
J Clin Oncol 23:8877-83. 2005..Our findings may have broad applicability because a 2005 Medicare initiative will provide the VA electronic medical record system as a free benefit to all US physicians... - The Research on Adverse Drug Events and Reports (RADAR) projectCharles L Bennett
Jesse Brown VA Medical Center Mid West Center for Health Services and Policy Research, Chicago, Ill 60611, USA
JAMA 293:2131-40. 2005.... - Amiodarone-associated optic neuropathy: a critical reviewRod S Passman
Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Am J Med 125:447-53. 2012..Legal blindness (<20/200) was noted in at least one eye in 20% of cases. Close ophthalmologic surveillance of patients during the tenure of amiodarone administration is warranted... - Cost considerations in the management of cancer in the older patientJune M McKoy
Division of Geriatrics, Robert H Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Division of Hematology Oncology, Chicago, Illinois 60611, USA
Oncology (Williston Park) 21:851-7; discussion 858, 860, 862 passim. 2007..Additional research about cancer costs may also lead to reforms in cancer care reimbursement, and therefore provide access to affordable health care for older patients... - Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) projectBeatrice J Edwards
Bone Health and Osteoporosis Center, Feinberg School of Medicine, Northwestern University, 676 North Saint Clair, Suite 1350, Chicago, IL 60611, USA
J Bone Joint Surg Am 95:297-307. 2013..S. FDA (Food and Drug Administration) Adverse Event Reporting System (FAERS) (1996 to 2011), published case reports, and international safety efforts... - Design of a prostate cancer patient navigation intervention for a Veterans Affairs hospitalNarissa J Nonzee
Robert H, Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA
BMC Health Serv Res 12:340. 2012.... - Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug AdministrationAnaadriana Zakarija
VA Chicago Healthcare System, VA Midwest Center for Health Services and Policy Research, Division of Hematology/Oncology, Department of Medicine, Northwestern University Medical Center, Chicago, Ill, USA
Stroke 35:533-7. 2004..Clopidogrel-associated TTP often occurs within 2 weeks of drug initiation, occasionally relapses, and has a high mortality if not treated promptly... - Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisitedElizabeth A Calhoun
Department of Health Policy and Administration, University of Illinois at Chicago, Chicago, IL 60612, USA
Pharmacoeconomics 23:767-75. 2005..Future cost-effectiveness studies of medications such as pegfilgrastim should attempt to capture the societal perspective by incorporating productivity-related costs and using base-case rates of FN reported in the literature... - Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screeningVeena Shankaran
MPP, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, 303 E Chicago Ave, Olson Pavilion Suite 8250, Chicago, IL 60611, USA
J Clin Oncol 25:5248-53. 2007..The objective of this secondary analysis is to assess the cost-effectiveness of this intervention... - Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program)Lauren Irizarry
Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Popul Health Manag 16:53-7. 2013..When diabetes coexists with cancer, management of diabetes often lags, making diabetes education an imperative... - Pure red-cell aplasia and epoetin therapyCharles L Bennett
MidWest Center for Health Services Research and Policy Studies, Jesse Brown Veterans Affairs Medical Center, Chicago, IL 60611, USA
N Engl J Med 351:1403-8. 2004.... - Opportunities for disease state management in prostate cancerA Simon Pickard
Department of Pharmacy Practice, Center for Pharmacoeconomic Research College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA
Dis Manag 8:235-44. 2005.... - Older patients' perceptions of medication importance and worth: an exploratory pilot studyDenys T Lau
Buehler Center on Aging, Health and Society, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA
Drugs Aging 25:1061-75. 2008..Cost-related medication non-adherence may be influenced by patients' perceived importance of their medications...